| id | Study | Lib. in paper | Exposition period | Study type  | 
                Control type  | 
                Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S4994 R13075  | 
                Drechsel, 2020 | Major congenital malformations | 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 2.53 [0.10;67.19] C | 0/9 1/66 | 1 | 9 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S4996 R13099  | 
                Fu, 2019 | Congenital malformations (majors) | 1st trimester | randomized controlled trial | unexposed, sick | Adjustment: Randomisation | 0.79 [0.05;12.80] C | 1/85 1/67 | 2 | 85 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S3011 R4360  | 
                Carman (Control unexposed, disease free), 2017 | Major malformations | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, disease free excluded | Adjustment: No | 
                    0.95 [0.49;1.85] C  excluded (control group)  | 
                
                11/210 59/1,078 | 70 | 210 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S3010 R4350  | 
                Carman (Control unexposed, sick), 2017 | Major malformations | during pregnancy (anytime or not specified) excluded | retrospective cohort (claims database) | unexposed, sick | Adjustment: No | 
                    1.08 [0.57;2.05] C  excluded (exposition period)  | 
                
                11/210 94/1,932 | 105 | 210 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S3004 R4288  | 
                Hoxha, 2017 | Congenital malformation | 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 0.19 [0.01;5.20] C | 0/17 1/11 | 1 | 17 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S4081 R8678  | 
                Bröms (controls unexposed, disease free), 2016 | Any major birth defect | 3 months or more before pregnancy or1st trimester | population based cohort retrospective | unexposed, disease free excluded | Adjustment: No | 
                    1.71 [1.13;2.59] C  excluded (control group)  | 
                
                24/344 52,592/1,250,192 | 52,616 | 344 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S3195 R5177  | 
                Bröms (controls unexposed, sick), 2016 | Any major birth defect | 3 months or more before pregnancy or1st trimester excluded | population based cohort retrospective | unexposed, sick | Adjustment: Yes | 
                    1.49 [0.92;2.28]  excluded (exposition period)  | 
                
                24/344 1,019/21,549 | 1,043 | 344 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S3137 R4912  | 
                Chambers, 2015 | Major birth defects in live born infants | at least 1st trimester | prospective cohort | unexposed, sick | Adjustment: Yes | 2.77 [1.04;7.35] | -/- -/- | - | - | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S2913 R4114  | 
                Weber-Schoendorfer, 2015 | Major birth defects | 1st trimester | prospective cohort | unexposed, disease free | Adjustment: No | 3.71 [1.47;9.40] C | 6/111 21/1,385 | 27 | 111 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S13722 R53453  | 
                Viktil (Controls exposed to other treatments), 2012 | Major malformations | 3 months or more before pregnancy or1st trimester | population based cohort propective | exposed to other treatment, sick excluded | Adjustment: No | 
                    0.37 [0.02;6.16] C  excluded (control group)  | 
                
                0/37 50/1,424 | 50 | 37 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S13723 R53455  | 
                Viktil (Controls unexposed, NOS), 2012 | Major malformations | 3 months or more before pregnancy or1st trimester excluded | population based cohort propective | unexposed (general population or NOS) | Adjustment: No | 
                    0.41 [0.03;6.70] C  excluded (exposition period)  | 
                
                0/37 5,000/154,976 | 5,000 | 37 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S4998 R13107  | 
                Hyrich, 2006 | Major fetal abnormalities | 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 0.79 [0.01;44.65] C | 0/10 0/8 | 0 | 10 | 
                    
                    
                         | 
                ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 6 studies | 2.61 [1.40;4.86] | 31 | 232 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asymetry test p-value = 0.0534 (by Egger's regression)
slope=1.7602 (0.3505); intercept=-1.2221 (0.4504); t=2.7132; p=0.0534
excluded 13722, 4081, 3011